
GlobalData’s Emerging Market Outsourcing report reveals that this push for domestic production could lead to increased production costs and inflationary…
This approval was followed by Takeda Pharmaceuticals’ Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and…
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical contract manufacturing organizations, GlobalData stated.
GlobalData’s research reveals that India accounted for around 20% of the Asia-Pacific (APAC) diabetes care devices market in 2024
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for 50% of the company’s…
GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.
Novartis plans to share STEER results with regulatory agencies including the FDA in 2025.
Given Wegovy’s success and record-high sales, a wave of investments has gone into the obesity space over the last couple…
In the era of artificial intelligence (AI), various trends have been observed that utilize AI in multiple sectors, having a…
The main reason for the expected increase in the 12-month and lifetime diagnosed prevalent cases of severe asthma is population…
The key drivers of the market growth include technological advancements, a rising geriatric population, and an increase in chronic diseases.
Parkinson’s Disease is among the most common chronic, progressive neurodegenerative disorders affecting the elderly population.
Early diagnosis and treatment prevent more extreme disease outcomes, such as blindness.
There are four dementia-specific medications approved in Australia – donepezil, galantamine, rivastigmine, and memantine.
According to GlobalData’s Sales and Forecast database, total sales for Tremfya are expected to reach $7.8 billion globally by 2029.
Ebglyss’ approval highlights the opportunity that exists in the AD space, and may have potential advantages in efficacy and safety…
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, and…
GlobalData’s research reveals that India accounted for around 13% of the Asia-Pacific (APAC) orthopedic devices market in 2024, driven by…